As of Sep 04
| +0.08 / +6.56%|
The 2 analysts offering 12-month price forecasts for Alexza Pharmaceuticals Inc have a median target of 2.13, with a high estimate of 3.00 and a low estimate of 1.25. The median estimate represents a +63.46% increase from the last price of 1.30.
The current consensus among 2 polled investment analysts is to Buy stock in Alexza Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.